Amonafide is a DNA intercalator and topoisomerase II inhibitor for the treatment of neoplastic diseases, one of Antitumor agent.
|In vitro||DMSO||57 mg/mL (201.17 mM)|
|Water||<1 mg/mL (<1 mM)|
|Ethanol||4 mg/mL (14.11 mM)|
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||35.3 mL||176.49 mL||352.98 mL|
|0.5 mM||7.06 mL||35.3 mL||70.6 mL|
|1 mM||3.53 mL||17.65 mL||35.3 mL|
|5 mM||0.71 mL||3.53 mL||7.06 mL|
*The above data is based on the productmolecular weight 283.3 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
|Synonyms||AS1413, Xanafide, Quinamed|